Screening platform for pharmaceuticals and industrial chemicals using stem cell-based 3D models of the human brain. BrainZell develops a new technology of cell-based models of the human brain and connects it with digital services for customers into a scalable platform. Our mini-brain organoid technology allows industries to enter a new testing era due to its low cost, flexibility, and resemblance to a real human brain. We serve customers who require large-scale, fidelity to human organs and flexible testing conditions.